CIK: 0001687078
Total reported value
$1.3B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Stock-Other | 27.58% | — | — | ||
| 2 | EPZMEUR | Epizyme INC | Stock-Other | 22.09% | — | — | |
| 3 | TCRRUSD | Tcr2 Therapeutics INC | Stock-Other | 15.94% | — | — | |
| 4 | GTHXEUR | G1 Therapeutics INC | Stock-Other | 9.58% | — | — | |
| 5 | TPB | Turning Point Brands, Inc. | Stock-Other | 8.42% | — | — | |
| 6 | ✓ | MEI Pharma, Inc. | Stock-Other | 6.15% | — | — | |
| 7 | YMABUSD | Y-mabs Therapeutics INC | Stock-Other | 5.38% | — | — | |
| 8 | CTMX | Cytomx Therapeutics INC | Stock-Other | 4.01% | — | — | |
| 9 | SNSSEUR | Viracta Therapeutics INC | Stock-Other | 0.71% | — | — | |
| 10 | AUTL | Autolus Therapeutics PLC | Stock-Other | 0.15% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | +7.2% | — | Unchanged | |
| 2 | EPZMEUR | Epizyme INC | +1.8% | — | Unchanged |
| 3 | YMABUSD | Y-mabs Therapeutics INC | +1.6% | — | Unchanged |
| 4 | CTMX | Cytomx Therapeutics INC | +1.5% | — | Unchanged |
| 5 | ✓ | MEI Pharma, Inc. | +0.7% | — | Unchanged |
| 6 | SNSSEUR | Viracta Therapeutics INC | +0.4% | — | Unchanged |
| 7 | AUTL | Autolus Therapeutics PLC | 0% | — | Unchanged |
| 8 | TCRRUSD | Tcr2 Therapeutics INC | -1.1% | — | Unchanged |
| 9 | GTHXEUR | G1 Therapeutics INC | -3.8% | — | Unchanged |
| 10 | ARQLUSD | Arqule INC | — | EXIT | Sold out |
| 11 | TPB | Turning Point Brands, Inc. | — | NEW | New buy |
| 12 | DCPHEUR | Deciphera Pharmaceuticals In | — | EXIT | Sold out |
| 13 | ARGX | Argenx Se - Adr | — | EXIT | Sold out |